TB-181-36

N/A

Report date: 2025/01/02 16:11:32

Base Information

Drug NameTB-181-36
Drug Alias NameTB181-36
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionImmunoglobulin G inhibitors
TargetsImmunoglobulin G
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTwist Bioscience CorpVanderbilt University Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesTwist Bioscience Corp
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A